Transmyocardial revascularization: Defining its role

Cardiology in Review

Volumn 13, Issue 1, 2005, Pages 52-55

  Goldberg, Ross F ^a   Fass, Arthur E ^c   Frishman, William H ^b  

^a ST VINCENT S HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c Phelps Memorial Hospital   (United States)

Author keywords

Angina pectoris; Angiogenesis; Laser therapy; Myocardial perfusion; Transmyocardial revascularization

Indexed keywords

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ANGIOPLASTY; BLOOD OXYGENATION; CARBON DIOXIDE LASER; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EPICARDIUM; FOOD AND DRUG ADMINISTRATION; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FAILURE; HISTORY OF MEDICINE; HUMAN; HYPOTENSION; LASER; LOW LEVEL LASER THERAPY; MAMMARY ARTERY; MORBIDITY; MORTALITY; NONHUMAN; PATIENT; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SYMPATHETIC INNERVATION; TISSUE INJURY; TREATMENT OUTCOME; YAG LASER;

ANGINA PECTORIS; ANIMALS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; HUMANS; LASER SURGERY; MYOCARDIAL REVASCULARIZATION;

EID: 13444263631     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000126080.01965.2e     Document Type: Review

References (40)

1. Vineberg AM. Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery. CMAJ. 1946;55:117-119.
2. Horvath KA, Smith WJ, Laurence RG, et al. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol. 1995;25:258-263.
3. 2 and Holmium:YAG lasers. Ann Thorac Surg. 1997;64:466-472.
4. Kohmoto T, Fisher PE, Gu A, et al. Does blood flow through Holmium: YAG transmyocardial laser channels? Ann Thorac Surg. 1996;61:861-868.
5. Myers J, Oesterle SN, Hones J, Burkhoff D. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J. 2002;143:1052-1057.
6. Al-Sheikh T, Allen KB, Straka SP, et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation. 1999; 100:135-140.
7. Horvath KA, Chiu E, Maun DC, et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg. 1999;68:825-829.
8. Hughes GC, Lowe JE, Kypson AP, et al. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg. 1998;66:2029-2036.
9. Yamamoto N, Kohmoto T, Gu A, et al. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol. 1998;31:1426-1433.
10. Pelletier MP, Giaid A, Sivaraman S, et al. Angiogenesis and growth factor expression in a model of transmyocardial revascularization. Ann Thorac Surg. 1998;66:12-18.
11. Kwong KG, Kannellopoulos GK, Nickols JC, et al. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 1997;114:883-890.
12. Bortone AS, D'Agostino D, Schena S, et al. Inflammatory response and angiogenesis after percutaneous transmyocardial laser revascularization. Ann Thorac Surg. 2000;70:1134-1138.
13. Zlotnick AY, Ahmad RM, Reul RM, et al. Neovascularization occurs at the site of closed laser channels after transmyocardial laser revascularization. Surg Forum. 1996;47:286-287.
14. Whittaker P, Rakusan K, Kloner RA. Transmural channels can protect ischemic tissue. Assessment of long-term myocardial response to laser-and needle-made channels. Circulation. 1996;93:143-152.
15. Aaberge L, Rootwelt K, Smith H-J, et al. Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonsance imaging methods. Scand Cardiovasc. J 2001;35:8-13.
16. Kavanagh GJ, Whittaker P, Prejean CA Jr, et al. Dissociation between improvement in angina pectoris and myocardial perfusion after transmyocardial revascularization with an excimer laser. Am J Cardiol. 2001;87:229-231.
17. Burns SM, Brown S, White CA, et al. Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization. Am J Cardiol. 2001;87:861-867.
18. Hamawy AH, Lee LY, Samy SA, et al. Transmyocardial laser revascularization dose response: enhanced perfusion in a porcine ischemia model as a function of channel density. Ann Thorac Surg. 2001;72:817-822.
19. Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomized controlled trial. Lancet. 1999;353:519-524.
20. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021-1028.
21. Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet. 1999;354:885-890.
22. Horvath KA, Cohn LH, Cooley DA, et al. Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg. 1997;113:645-654.
23. 2 laser in patients with refractory angina pectoris: Clinical results from the Norwegian Randomized Trial. J Am Coll Cardiol. 2000;35:1170-1177.
24. 2 laser: A late clinical follow-up of the Norwegian Randomized Trial With Transmyocardial Revascularization. J Am Coll Cardiol. 2002;39:1588-1593.
25. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029-1036.
26. Stone GW, Teirstein PS, Rubenstein R, et al. A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol. 2002;39:1581-1587.
27. Jones JW, Schmidt SE, Richman CC, et al. Helmium:YAG laser transmyocardial revascularization relieves angina and improves functional status. Ann Thorac Surg. 1999;67:1596-1602.
28. Oesterle SN, Sanborn TA, Ali N, et al. Percutaneous transmyocardial laser revascularization for severe angina: the PACIFIC randomized trial. Lancet. 2000;356:1705-1710.
29. Horvath KA, Mannting F, Cummings N, et al. Transmyocardial laser revascularization: Operative techniques and clinical results at two years. J Thorac Cardiovasc Surg. 1996;111:1047-1053.
30. Mukherjee D, Bhatt DL, Roe MT, et al. Direct myocardial revascularization and angiogenesis - How many patients might be eligible? Am J Cardiol. 1999;84:598-600.
31. 2 laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial. Am J Med. 2001; 111:341-348.
32. Stamou SC, Boyce SW, Cooke RH, et al. One-year outcome after combined coronary artery bypass grafting and transmyocardial laser revascularization for refractory angina pectoris. Am J Cardiol. 2002;89:1365-1368.
33. Whitlow PL, DeMaio SJ Jr, Perin EC, et al. for the Eclipse Investigators: One-year results of percutaneous myocardial revascularization for refractory angina pectoris. Am J Cardiol. 2003;91:1342-1346.
34. 2 laser. Circulation. 2001;104(suppl I):I-81-I-84.
35. Lee LY, O'Hara MF, Finnin EB, et al. Transmyocardial laser revascularization with excimer laser: clinical results at 1 year. Ann Thorac Surg. 2000;70:498-503.
36. Burkhoff D, Wesley MN, Resar JR, Lansing AM. Factors correlating with risk of mortality after transmyocardial revascularization. J Am Coll Cardiol. 1999;34:55-61.
37. Bridges CR. Myocardial Laser Revascularization: the Controversy and the Data. Ann Thorac Surg. 2000;69:655-662.
38. Hughes GC, Shah AS, Yin B, et al. Early postoperative changes in regional systolic and diastolic left ventricular function after transmyocardial laser revascularization. J Am Coll Cardiol. 2000;35:1022-1030.
39. 2 laser. Scand Cardiovasc J. 2001;35:19-24.
40. Frishman WH, Wolff AI, Lee W-N, et al. The placebo effect in cardiovascular disease. In: Frishman WH, Weintraub MI, Micozzi M, eds. Complementary and Integrative Therapies for Cardiovascular Disease. St. Louis: Elsevier; 2005:2-28.